Market Place
Sourcing Support
All News #Library
Biotech
Biotech Sells 4 Cell Therapy Programs for $55M
28 Jul 2025 //
FIERCE BIOTECH
Adaptimmune questions own longevity, axes preclinical funding
20 Mar 2025 //
FIERCE BIOTECH
AGC Biologics to Support Adaptimmune’s Solid Tumor Cell Therapy
16 Jan 2025 //
CONTRACTPHARMA
Adaptimmune`s cell therapy hits key goal in pivotal sarcoma test
13 Nov 2024 //
FIERCE BIOTECH
First-of-its-kind cell therapy approved by FDA for rare soft tissue cancer
03 Aug 2024 //
PRESS RELEASE
Adaptimmune Gears Up for Potential Approval of First-in-Class Engineered T Cell Therapy
29 Jul 2024 //
BIOSPACE
Roche, Adaptimmune part ways on cell therapy research
13 Apr 2024 //
BIOPHARMADIVE
GSK pays out £30M to Adaptimmune as cell therapy work ends
11 Apr 2023 //
FIERCE BIOTECH
Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company
06 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.